Sourcing & Management of Health Products - Updates

Opportunity for Evaluation of Pharmaceutical Products - Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial Medicines

29 June 2022

The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP). This evaluation will concern Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial medicines. Detailed information about the review process and submission requirements can be found on the Expert Review Panel page.

The deadline for the Submission is the 19th August 2022.

Invitation to Manufacturers to Submit an Expression of Interest for Product Evaluation by the Global Fund Expert Review Panel for Pharmaceutical Products
download in English